ASIA PACIFIC CLINICAL NUTRITION MARKET FORECAST 2019-2028

  • You are here:
  • Home
  • Reports
  • ASIA PACIFIC CLINICAL NUTRITION MARKET FORECAST 2019-2028

ASIA PACIFIC CLINICAL NUTRITION MARKET FORECAST 2019-2028

The Asia Pacific clinical nutrition market is predicted to garner a CAGR of 5.75%, across the forecast period of 2019 to 2028. The key drivers of accelerating the market growth include, the advancing R&D division, developments in healthcare reforms, and technological improvements within healthcare avenues. The Asia Pacific clinical nutrition market growth is determined through the analysis of China, Indonesia, Vietnam, India, Japan, Thailand, Australia & New Zealand, South Korea, and the rest of the Asia Pacific.

ASIA PACIFIC CLINICAL NUTRITION MARKET FORECAST 2019-2028

Asia Pacific Clinical Nutrition Market by Route of Administration (Oral, Enteral, Parenteral) by Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders, Other Applications) by End-user (Pediatric, Geriatric, Adults) and by Geography.

Request free sample

The Asia Pacific clinical nutrition market is predicted to garner a CAGR of 5.75%, across the forecast period of 2019 to 2028. The key drivers of accelerating the market growth include, the advancing R&D division, developments in healthcare reforms, and technological improvements within healthcare avenues.
asia pacific clinical nutrition market

To know more about this report, request a free sample copy

The Asia Pacific clinical nutrition market growth is determined through the analysis of China, Indonesia, Vietnam, India, Japan, Thailand, Australia & New Zealand, South Korea, and the rest of the Asia Pacific. The increasing geriatric population, rising prevalence of lifestyle-oriented diseases, high healthcare expenditures, upgrading health standards, and the upsurge in the number of children suffering from malnutrition, are attributed to the growing demand for clinical nutrition in Japan. The country is one of the most profitable markets for geriatric clinical nutrition, as more than 20% of the Japanese population is over the age of 65. Besides, one in five people is predicted to be over 70 years in Japan, by the next decade. The country also possesses one among the highest life expectancies of over 84 years.

Japan’s residents are highly health-conscious and primarily concentrate on consuming a wholesome, nutritious, and balanced diet. Thus, the rise in the elderly populace, in addition to the widespread need for maintaining a healthy standard of living, is anticipated to raise the region’s demand for nutritional and dietary supplements.

Otsuka Holdings Co. Ltd., headquartered in Japan, is mainly involved in pharmaceutical and medical-related businesses. The company’s product, HineBag, is a comprehensive nutritional food product comprising well-balanced nutrients. It is suitable for individuals who cannot obtain sufficient nutrients with a regular diet, because of medical conditions.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • MARKET DEFINITION
    •    KEY DRIVERS
      • INCREASING PREVALENCE OF CHRONIC DISEASES AND LIFESTYLE ASSOCIATED DISEASE
      • RISE IN ELDERLY POPULATION
      • HIGH OCCURRENCE OF MALNUTRITION AMONG HOSPITALIZED PATIENTS
      • SURGING DEMAND IN DEVELOPING ECONOMIES
    •    KEY RESTRAINTS
      • LACK OF AWARENESS FOR CLINICAL NUTRITION
      • COMPLICATIONS ASSOCIATED WITH ENTERAL FEEDING
      • STRINGENT REGULATIONS
  1. KEY ANALYTICS
    •    PORTER’S FIVE FORCE ANALYSIS
      • THREAT OF NEW ENTRY
      • THREAT OF SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • COMPETITIVE RIVALRY
    • IMPACT OF COVID-19 ON CLINICAL NUTRITION MARKET
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • KEY INVESTMENT INSIGHTS
  2. MARKET BY ROUTE OF ADMINISTRATION
    • ORAL
    • ENTERAL
    • PARENTERAL
  3. MARKET BY APPLICATION
    • CANCER
    • NEUROLOGICAL DISEASES
    • GASTROINTESTINAL DISORDERS
    • METABOLIC DISORDERS
    • OTHER APPLICATIONS
  4. MARKET BY END-USER
    • PEDIATRIC
    • GERIATRIC
    • ADULTS
  5. GEOGRAPHICAL ANALYSIS
    •    ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA & NEW ZEALAND
      • SOUTH KOREA
      • THAILAND
      • INDONESIA
      • VIETNAM
      • REST OF ASIA PACIFIC
  1. COMPANY PROFILES
    • ABBOTT LABORATORIES
    • AMERICAN REGENT INC
    • BASF SE
    • BAXTER INTERNATIONAL INC
    • B BRAUN
    • DANONE
    • EXELA PHARMA SCIENCES
    • GRIFOLS SA
    • LONZA LTD
    • MEIJI HOLDINGS CO LTD
    • NESTLE HEALTH SCIENCE
    • OTSUKA HOLDINGS CO LTD
    • RECKITT BENCKISER GROUP PLC
    • SANOFI
    • SICHUAN KELUN PHARMACEUTICAL CO LTD

TABLE LIST

TABLE 1: MARKET SNAPSHOT – CLINICAL NUTRITION

TABLE 2: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 3: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 4: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 5: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 6: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 7: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 8: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 9: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

FIGURES LIST 

FIGURE 1: MAJOR CATEGORIES OF ASIA PACIFIC HEALTH SPENDING, 2017

FIGURE 2: COMPLICATIONS OF ENTERAL FEEDING

FIGURE 3: PORTER’S FIVE FORCE ANALYSIS

FIGURE 4: OPPORTUNITY MATRIX

FIGURE 5: VENDOR LANDSCAPE

FIGURE 6: KEY INVESTMENT INSIGHTS

FIGURE 7: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, IN 2019

FIGURE 8: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY ORAL, 2019-2028 (IN $ MILLION)

FIGURE 9: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY ENTERAL, 2019-2028 (IN $ MILLION)

FIGURE 10: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY PARENTERAL, 2019-2028 (IN $ MILLION)

FIGURE 11: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY APPLICATION, IN 2019

FIGURE 12: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY CANCER, 2019-2028 (IN $ MILLION)

FIGURE 13: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY NEUROLOGICAL DISEASES, 2019-2028 (IN $ MILLION)

FIGURE 14: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY GASTROINTESTINAL DISORDERS, 2019-2028 (IN $ MILLION)

FIGURE 15: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY METABOLIC DISORDERS, 2019-2028 (IN $ MILLION)

FIGURE 16: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ MILLION)

FIGURE 17: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY END-USER, IN 2019

FIGURE 18: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY PEDIATRIC, 2019-2028 (IN $ MILLION)

FIGURE 19: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY GERIATRIC, 2019-2028 (IN $ MILLION)

FIGURE 20: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY ADULTS, 2019-2028 (IN $ MILLION)

FIGURE 21: ASIA PACIFIC CLINICAL NUTRITION MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 22: JAPAN CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 23: CHINA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 24: INDIA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 25: AUSTRALIA & NEW ZEALAND CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 26: SOUTH KOREA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 27: THAILAND CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 28: INDONESIA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 29: VIETNAM CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

FIGURE 30: REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    •    ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA & NEW ZEALAND
      • SOUTH KOREA
      • THAILAND
      • INDONESIA
      • VIETNAM
      • REST OF ASIA PACIFIC
  1. MARKET BY ROUTE OF ADMINISTRATION
    • ORAL
    • ENTERAL
    • PARENTERAL
  2. MARKET BY APPLICATION
    • CANCER
    • NEUROLOGICAL DISEASES
    • GASTROINTESTINAL DISORDERS
    • METABOLIC DISORDERS
    • OTHER APPLICATIONS
  3. MARKET BY END-USER
    • PEDIATRIC
    • GERIATRIC
    • ADULTS

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now